Suchergebnisse - "Yang, Yunpeng"

PubPharm (307)

1

State-owned capital and quality of green innovation : Evidence from Chinese listed private firms

enthalten in: Heliyon | 2024

von Yan, H. | Chen, Z. | Yang, Y.

2

Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study

enthalten in: Cancer communications (London, England) | 2024

von Zheng, J. | Wang, T. | Yang, Y. | +41

3

Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy : A multicohort, open-label, phase II trial with biomarker analysis

enthalten in: Cancer medicine | 2024

von Zhang, Y. | Chen, Z. | Liu, Y. | +14

4

Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Guan, S. | Chen, X. | Wei, Y. | +15

5

GutEggerthella lentapromotes the efficacy of resveratrol through reductive metabolism

enthalten in: bioRxiv.org | 2024

von Dong, Z. | Yu, P. | Zhou, H. | +5

6

Trends in pain undertreatment among lung cancer patients at the EOL : Analysis of urban city medical insurance data in China

enthalten in: Thoracic cancer | 2024

von Zheng, J. | Huang, Y. | He, J. | +8

7

Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma

enthalten in: NPJ precision oncology | 2024

von Ma, Y. | Zhou, H. | Luo, F. | +12

8

Intracranial response pattern, tolerability and biomarkers associated with brain metastases in non-small cell lung cancer treated by tislelizumab plus chemotherapy

enthalten in: Translational lung cancer research | 2024

von Zhao, S. | Jiang, W. | Yang, N. | +9

9

Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin's lymphoma

enthalten in: Cell reports. Medicine | 2024

von Ma, Y. | Luo, F. | Zhang, Y. | +15

10

QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer : a multi-cohort, phase II study

enthalten in: Signal transduction and targeted therapy | 2024

von Huang, Y. | Yang, Y. | Zhao, Y. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]